PATENT CLAIM ANALYSIS

Application Number: 15975466
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-10
Patent Classification: ["514", "210210"]

Abstract:
The disclosure is directed to novel dopamine D3 receptor antagonists, processes for their preparation, intermediates used in these processes, pharmaceutical compositions containing them and their use in therapy, including treating drug dependency and psychosis.

Claim (Index 30):
A method for treating opioid use disorder in a mammal in need thereof, the method comprising administering to the mammal an effective amount of the compound of  claim 25  to treat the opioid use disorder.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 93.0
- Lexical Diversity: 1.21875
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15522863', '15767328', '14213169', '15750128', '12680792']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7214336903029982
- 35 USC 102 Novelty (BERT): 0.5491073184702011
- Combined Prediction Score: 0.7042010531197185
- Mean Citation Score: 287.50429
- Max Citation Score: 391.35886
- Similarity Product: 327.3816892975688

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test